Every ingredient meets the PurePath Standard, ensuring pure, effective nutrients free from fillers, pesticides, herbicides, or synthetic additives
The timeline for such developments typically extends 2-3 years beyond Phase 3 trial completion, placing potential regulatory milestones in the 2027-2028 timeframe
LeePHPerlisRHJungJYByrneEMRueckertESiburianRet al
The early wins are about how you feel, and the visible results build with consistency, usually becoming noticeable after six to eight weeks
Quick Takeaways Human sleep trials used 25 nmol/kg IV for 7 consecutive nights The commonly used 100250 mcg subcutaneous protocol lacks direct clinical validation DSIP demonstrates an unusually wide safety margin in animal and human research Most evidence comes from small 1980s pilot studies, not modern RCTs What DSIP Actually Is (And Why Its Misunderstood) DSIP is a nine-amino-acid neuropeptide first isolated in 1977 from the cerebral venous blood of sleeping rabbits